Comparison of the Prevalence of the Metabolic Syndrome by WHO, AHA/NHLBI, and IDF Definitions in a German Population with Type 2 Diabetes: The Diabetes in Germany (DIG) Study

Koehler, Carsta; Ott, P.; Benke, I.; Hanefeld, Markolf

doi:10.1055/s-2007-985816

Cited by 42 publications

(40 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…On the other hand, several reports have shown that hypertension is very prevalent among Europeans with DM and the highest and the lowest rates were 95% and 29.3%, respectively [27][28][29]. In USA, 70.9% was the highest prevalence of hypertension among type 2 DM patients and the lowest prevalence reported was 66.9% [30].…”

Section: Discussionmentioning

confidence: 93%

Prevalence of Hypertension and Obesity among Emirati Patients with Type 2 Diabetes

Mussa¹,

Abduallah²

2015

J Diabetes Metab

View full text Add to dashboard Cite

Introduction: Hypertension and obesity are key risk factors for long-term complications associated with type 2 diabetes mellitus (type 2 DM). Previous studies have shown that the prevalence of hypertension and obesity is high in the United Arab of Emirates (UAE). However, none of these studies has focused on the investigation of hypertension and obesity in Emirati patients with type 2 DM. Methodology:The present study is a retrospective observational study which was conducted in Rashid Centre for Diabetes and Research (Ajman, UAE). Medical records for 510 diabetic Emirati patients were examined and 51 medical records were excluded due to incomplete or missing medical data. 459 medical records of Emirati patients with type 2 DM were filtered, examined and analyzed and the following variables were included in the investigation: anthropometric variables, diabetes type and duration, BMI, HbA1c, blood pressure and lipid profile. Results and conclusions:Findings of the present study have demonstrated that the prevalence of hypertension and obesity in Emirati patients with type 2 DM were 63% and 57%, respectively. Compared to non-hypertensive patients, hypertensive patients with type 2 DM were older and had higher levels of HbA1C and about 60% of the hypertensive patients were obese. A strong positive relationship between the systolic blood pressure, and age and diabetes duration was observed whereas the diastolic blood pressure was negatively correlated with age and diabetes duration. The prevalence of hypertension and obesity among Emirati patients with type 2 DM was significantly high. Age and diabetes duration have opposite effects on systolic and diastolic blood pressure.

show abstract

Section: Discussionmentioning

confidence: 93%

Prevalence of Hypertension and Obesity among Emirati Patients with Type 2 Diabetes

Mussa¹,

Abduallah²

2015

J Diabetes Metab

View full text Add to dashboard Cite

show abstract

“…The clustering of risk factors for CVD is seen as a universal phenomenon among people with type 2 diabetes [10][11][12][13][14]. MS is also a stronger and independent predictor for heart disease in type 2 diabetic patients [10,14].…”

Section: Discussionmentioning

confidence: 99%

“…There is considerable evidence to suggest that modification of these factors results in a substantial decrease and delay in the development of heart diseases [8,9]. Metabolic syndrome (MS) is a clustering of such risk factors and its prevalence is found to be nearly 60% to 80% among diabetic patients in different parts of the world [10][11][12][13]. Although, MS is known as a significant and independent predictor of cardiovascular disease, its presence among persons with type 2 diabetes raises this risk to the greatest [10,14,15].…”

Section: Introductionmentioning

confidence: 99%

Metabolic syndrome and its individual components among people with type 2 diabetes: Prevalence, gender differences and its association with ischemic heart disease

Khuwaja¹,

Ali²,

Naqvi³

et al. 2012

JDM

View full text Add to dashboard Cite

Background: Metabolic syndrome (MS) is common among people with type 2 diabetes. The purpose of this study was to assess the proportion of MS and its individual components among type 2 diabetic adults, to stratify these by gender and to determine their association with ischemic heart disease (IHD). Method: A cross-sectional multicentre study was conducted in public and private sector clinics in Karachi, Pakistan. A pretested structured questionnaire and medical records were used to collect information from 889 people with type 2 diabetes after informed consent. Chi-square test and odds ratios with 95% CI were used to assess the association of MS, its components and IHD. Adjusted odds ratios were used to evaluate the differences of MS and its components by gender. Results: In all, 70% of the participants had MS. The likelihood of having IHD among those with MS was higher (OR = 3.21; 95% CI = 2.22 -4.65). Of the individual MS components, obesity conferred the strongest association with IHD (OR = 2.57; 95% CI = 1.91 -3.43). Multivariate analysis showed an increased proportion of MS among women (AOR = 1.63; 95% CI = 1.18 -2.24). Of the individual MS components, women had a higher prevalence of obesity (AOR = 4.70; 95% CI = 3.30 -6.70). Conclusion: A very high burden of MS among type 2 diabetics has been identified in this study. Dedicated interventions are needed to prevent/ delay the onset of MS and the associated morbidity and mortality.

show abstract

“…The major features of the 32 These definitions are having many similarities, however, they differ in some of their components and cut-offs. In the general population, prevalence of the MetS vary according to the definition used 33 and its prevalence increases with age. 34,35 The prevalence of MetS in patients with RA in various published studies is shown in Table 1.…”

Section: Metabolic Syndromementioning

confidence: 99%

Metabolic syndrome in patients with rheumatoid arthritis: clinical implications

B¹,

G²,

DT³

et al. 2013

JCSR

View full text Add to dashboard Cite

Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by swelling, tenderness, and destruction of synovial joints, leading to severe disability and premature mortality. The severity of inflammation is linked to an increased risk of cardiovascular mortality in the affected persons. Patients with RA are more prone for accelerated atherosclerosis than the general population. Atherosclerosis is in turn a risk factor for cardiovascular disease (CVD). Metabolic syndrome (MetS) is a major risk factor for the development of CVD. Evaluation of patients with RA for MetS appears to be clinically relevent because, not only are patients with RA more prone to develop atherosclerotic CVD, but when an associated MetS coexists this risk is further amplified. Investigations into the relationship between RA and the MetS have yielded conflicting results. While some studies reported a higher prevalence of MetS in patients with RA, others did not document such association. It has also been demonstrated that drugs which decrease rheumatoid inflammation are also useful in decreasing the MetS component of the disease.

show abstract

Comparison of the Prevalence of the Metabolic Syndrome by WHO, AHA/NHLBI, and IDF Definitions in a German Population with Type 2 Diabetes: The Diabetes in Germany (DIG) Study

Cited by 42 publications

References 3 publications

Prevalence of Hypertension and Obesity among Emirati Patients with Type 2 Diabetes

Prevalence of Hypertension and Obesity among Emirati Patients with Type 2 Diabetes

Metabolic syndrome and its individual components among people with type 2 diabetes: Prevalence, gender differences and its association with ischemic heart disease

Metabolic syndrome in patients with rheumatoid arthritis: clinical implications

Contact Info

Product

Resources

About